Skip to main content
FinSpry Logo
FinSpry
CRBP logo
CRBP
(NASDAQ)
Corbus Pharmaceuticals Holdings, Inc.
$8.25-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Corbus Pharmaceuticals Holdings, Inc. stock.

Analyst Consensus Rating

Investment consensus from 8 professional research analysts

Consensus Rating

Buy
Based on 8 unique analysts
(9 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$41.00
↑ 396.97% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest CRBP Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Paul Jeng
Guggenheim
BuyMaintains
$45.00
Andres Y. Maldonado
HC Wainwright
BuyReiterates
$40.00
Jeff Jones
Oppenheimer
BuyReiterates
$54.00
Andy Hsieh
William Blair
BuyMaintains
-
Robert Driscoll
Wedbush
BuyReiterates
$38.00 → $30.00
Graig Suvannavejh
Mizuho
BuyReiterates
$44.00
Oliver McCammon
LifeSci Capital
BuyMaintains
$38.00
Brian Abrahams
RBC Capital
BuyMaintains
$51.00 → $36.00
Paul Jeng
Guggenheim
Strong BuyInitiates
$45.00

Frequently Asked Questions

What is the analyst consensus rating for CRBP?

The analyst consensus rating for CRBP is "Buy" based on 8 analyst recommendations.

What is the average price target for CRBP?

The average 12-month price target for CRBP is $41.00, representing an upside of 397.0% from the current price of $8.25.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.